Abstract
The ongoing Diabetes among Latinos Best Practices Trial (DIALBEST) has randomly assigned Latinos with type 2 diabetes to the standard of clinical care or the intervention group that receives home visits from peer counselors. Intervention group participants receive one weekly visit during the first month, biweekly during months 2 and 3, and monthly thereafter until month 12.Groups were equivalent at baseline with regards to their socio‐economic, demographic, and biomarker characteristics. The intervention group continues to have a greater improvement in HbA1c at 3 months compared to the control group (‐1.1 ± 1.6 % vs. ‐0.5 ± 1.7 %, n=130, p=0.04). Although not statistically significant, because we still have not reached the desired statistical power, by 6 months the between group differences remain in favor of the intervention group (‐0.8 ± 1.6 % vs. ‐0.4 ± 1.4 %, n=82) with similar trends seen at 12 months (‐0.7 ± 2.2 % vs. ‐0.1 ± 1.7 %, n=48). Thus, the short term DIALBEST benefits on glycemic control are likely to continue in the longer term. Funded by The Connecticut Latino Health Disparities NIH EXPORT Center (NIH‐NCMHD grant # P20MD001765).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
